- Patients will have better treatment and medical care comfort, as well as the awareness that an expert who treats a woman will be able to help her so that she recovers. This is a milestone in European standards, said MP Barbara Dziuk in an interview with Medexpress, commenting on the changes in the November list of reimbursed drugs that are important for breast cancer patients. She also drew attention to the need for prophylaxis and education, from an early age to senior age.
In October we managed to announce a very important news for breast cancer patients. It is about inclusion in the November reimbursement list of modern therapies used in the treatment of a triple-negative cancer subtype. What does this mean for patients?
This means that patients will have better treatment and medical care comfort, as well as the aw...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
